Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: An updated review.

Authors

Gavin Lockard, Lehigh Valley Health NetworkFollow
Jonah Gordon
Samantha Schimmel
Bassel El Sayed
Molly Monsour
Svitlana Garbuzova-Davis
Cesar V Borlongan

Publication/Presentation Date

12-1-2023

Abstract

Amyotrophic lateral sclerosis (ALS) is a rapidly fatal neurological disease characterized by upper and lower motor neuron degeneration. Though typically idiopathic, familial forms of ALS are commonly comprised of a superoxide dismutase 1 (SOD1) mutation. Basic science frequently utilizes SOD1 models

Volume

1

Issue

2

First Page

130

Last Page

138

ISSN

2770-730X

Published In/Presented At

Lockard, G., Gordon, J., Schimmel, S., Sayed, B. E., Monsour, M., Garbuzova-Davis, S., & Borlongan, C. V. (2023). Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: An updated review. Neuroprotection, 1(2), 130–138. https://doi.org/10.1002/nep3.26

Disciplines

Medical Education | Medicine and Health Sciences

PubMedID

38188233

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article